门德尔的随机化揭示了阿尔茨海默病中氨基酸β和之间的单向联系
Jun Pyo Kim1, Hyunwoo Lee2,3, Bo-Hyun Kim2
1Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Dementia and neurocognitive disorders
|November 12, 2025
概括
阿尔茨海默病的研究证实,粉样β (Aβ) 积累导致病理. 这项研究使用了门德尔的随机化来确定Aβ作为阿尔茨海默病进展的上游因素.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学是一种遗传学.
- 生物标志物 生物标志物
背景情况:
- 粉样β (Aβ) 生物标志物变化被认为在阿尔茨海默病 (AD) 中先于变化.
- 建立Aβ和tau病理之间的因果关系是具有挑战性的.
- 之前的研究表明时间序列,但缺乏明确的因果证据.
研究的目的:
- 调查阿尔茨海默病 (AD) 中的粉样β (Aβ) 和生物标志物之间的因果关系.
- 为了确定Aβ和tau之间的因果关系的方向性.
- 使用门德尔随机化 (MR) 进行强大的因果推理.
主要方法:
- 两个样本的门德尔随机化 (MR) 分析使用GWAS总结统计数据进行.
- 全基因组关联研究 (GWAS) 的数据包括Aβ正子发射断层扫描 (PET) 和脑脊液酸化 (CSF pTau).
- 验证使用tau PET GWAS和一个样本MR进行了验证,其中包括神经质斑块和神经纤维状结负担的尸检数据.
主要成果:
- 在Aβ积累和CSFpTau水平之间发现了显著的因果关系 (BETA=0.30,p=0.004).
- 没有证据支持CSF pTau与Aβ积累的因果关系 (p=0.56).
- 进一步的分析证实了从Aβ负担 (神经质斑块) 到tau负担 (神经纤维状) 的因果方向 (p=1.24×10−13).
结论:
- 研究结果强烈表明,在阿尔茨海默病中,Aβ积累先于并驱动tau病理时存在因果关系.
- 粉样蛋白-β (Aβ) 已被证实是AD病变发生的关键上游因素.
- 这强化了阿尔茨海默病中的粉样蛋白级联假说.
更多相关视频
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
8.3K
10:02Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
27.9K
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
